GoodRx Holdings, Inc. (GDRX)
NASDAQ: GDRX · Real-Time Price · USD
3.660
-0.020 (-0.54%)
Aug 10, 2026, 4:00 PM EDT - Market closed
GoodRx Holdings Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Operating Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 16.25 | 30.44 | 16.39 | -8.87 | -32.83 | -25.25 |
Depreciation & Amortization | 88.64 | 85.22 | 69.54 | 107.67 | 54.18 | 34.54 |
Stock-Based Compensation | 69.14 | 76.63 | 99.03 | 104.82 | 120.23 | 160.46 |
Other Adjustments | 37.95 | 32.07 | -3.16 | -43.39 | 25.49 | 20.83 |
Change in Receivables | 8.68 | -88.02 | -2.33 | -26.47 | 1.38 | -43.95 |
Changes in Accounts Payable | -16.85 | 4.1 | -15.82 | 12.03 | -0.87 | 4.21 |
Changes in Accrued Expenses | 20.48 | 1.19 | 9.91 | 21.25 | -5.27 | 14 |
Changes in Other Operating Activities | -5.37 | 26.28 | 10.33 | -28.76 | -15.52 | 13.95 |
Operating Cash Flow | 201.58 | 167.9 | 183.89 | 138.29 | 146.78 | 178.78 |
Operating Cash Flow Growth | 5.76% | -8.69% | 32.97% | -5.78% | -17.90% | 36.12% |
Investing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Capital Expenditures | -4.49 | -3.52 | -1.24 | -1.04 | -3.97 | -4.57 |
Purchases of Intangible Assets | -65.4 | -70.5 | -69.11 | -54.72 | -51.25 | -29.89 |
Cash Acquisitions | -13.44 | -43.44 | - | - | -156.85 | -140.27 |
Proceeds from Business Divestments | - | - | - | - | 16.58 | - |
Other Investing Activities | - | -2.5 | - | - | -15.01 | -4.01 |
Investing Cash Flow | -85.82 | -119.96 | -70.35 | -55.77 | -210.5 | -178.73 |
Financing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Long-Term Debt Issued | - | - | 472.03 | - | - | - |
Long-Term Debt Repaid | -5 | -5 | -639.04 | -5.27 | -7.03 | -7.03 |
Net Long-Term Debt Issued (Repaid) | -5 | -5 | -167.01 | -5.27 | -7.03 | -7.03 |
Issuance of Common Stock | 0.97 | 1.37 | 20.81 | 7.33 | 9.16 | 35.02 |
Repurchase of Common Stock | -96.93 | -230.84 | -188.63 | -169.46 | -122.36 | -57.69 |
Net Common Stock Issued (Repurchased) | -95.96 | -229.47 | -167.82 | -162.12 | -113.2 | -22.67 |
Other Financing Activities | - | - | -2.67 | - | - | -0.83 |
Financing Cash Flow | -100.96 | -234.47 | -337.5 | -167.4 | -120.23 | -30.53 |
Net Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Cash Flow | 14.8 | -186.53 | -223.95 | -84.87 | -183.94 | -30.48 |
Free Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 197.09 | 164.38 | 182.65 | 137.25 | 142.81 | 174.21 |
Free Cash Flow Growth | 4.01% | -10.00% | 33.08% | -3.90% | -18.02% | 57.24% |
FCF Margin | 25.10% | 20.63% | 23.05% | 18.29% | 18.63% | 23.37% |
Free Cash Flow Per Share | 0.57 | 0.46 | 0.47 | 0.33 | 0.35 | 0.42 |
Levered Free Cash Flow | 93.66 | 138.71 | -77.9 | 97.02 | -11.31 | 29.84 |
Unlevered Free Cash Flow | 111.83 | 160.37 | 107.02 | 106.85 | 31 | 95.39 |